Comparative Analysis Affordable Care Act Updated Vaccines Vaccine Efficacy Moderna and Pfizer FDA Approval Comirnaty Insurance Coverage Covaxin Oxford-AstraZeneca Vaccine
The pharmaceutical giant beat revenue and earnings estimates, yet its stock remains flat as challenges loom in 2025.